Drugs / Tenofovir Alafenol Fumarate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07002268 | Mar → May 2022 | — | Henan Genuine Biotech Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenofovir Alafenol Fumarate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07002268 ↗ |
| Known as | TAF | “Azvudine tablets(FNC) and Tenofovir Alafenol Fumarate Tablets (TAF)” NCT07002268 ↗ |